Search results for "Transdermal"

showing 10 items of 68 documents

Equipotent doses to switch from high doses of opioids to transdermal buprenorphine.

2008

INTRODUCTION: The aim of this study was to evaluate the equianalgesic ratio of transdermal buprenorphine (TD BUP) with oral morphine and TD fentanyl in a sample of consecutive cancer patients receiving stable doses of 120-240 mg of oral morphine or 50-100 microg of TD fentanyl, reporting adequate pain and symptom control. MATERIALS, METHODS, AND RESULTS: Patients receiving daily stable doses of opioids for more than 6 days, with no more than two doses of oral morphine (20 and 40 mg, respectively) as needed, were switched to TD BUP using a fentanyl-BUP ratio of 0.6:0.8 and an oral morphine-BUP ratio of 70:1. Opioid doses, pain and symptom intensity, global satisfaction, and number of breakth…

Maletransdermal buprenorphinePainAdministration CutaneousFentanylNeoplasmsHigh dosesMedicineHumansSymptom controlProspective StudiesOral morphineAgedDose-Response Relationship Drugbusiness.industryMiddle AgedEquianalgesicBuprenorphineAnalgesics OpioidFentanylOncologyPatient SatisfactionAnesthesiaFemaleTransdermal Buprenorphinehigh doses of opioidsbusinessCancer painmedicine.drugSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate

2010

The aim of the present study was to develop a sumatriptan succinate transdermal system for applying migraine treatments efficiently and easily. For this system polyvinyl alcohol was employed as a matrix and Azone((R)) was added as a permeability enhancer. The physical characteristics, mechanical properties, and in vivo bioadhesion of the systems were evaluated, as was in vitro permeation across porcine skin. A uniform distribution of the drug in the matrix was observed, and moisture uptake values were constant. With regard to mechanical parameters, occlusive layer inclusion made the system more resistant, and no significant differences were detected with respect to other systems. Although A…

Materials scienceChemistry PharmaceuticalDrug CompoundingMigraine DisordersSkin AbsorptionPharmaceutical SciencePharmacologyAdministration CutaneousPolyvinyl alcoholPermeabilitychemistry.chemical_compoundDrug Delivery SystemsDrug StabilityIn vivoSumatriptan SuccinatemedicineTechnology PharmaceuticalVasoconstrictor AgentsDrug InteractionsAntihypertensive AgentsTransdermalDrug CarriersSumatriptanAzepinesGeneral MedicineHydrogen-Ion ConcentrationPermeationSerotonin Receptor AgonistsSumatriptanSolubilitychemistryPermeability (electromagnetism)Polyvinyl AlcoholPolyvinylsAzoneBiomedical engineeringmedicine.drugDrug Delivery
researchProduct

Efficacy of fentanyl transdermal patch in pain control after lower third molar surgery: A preliminary study

2015

Background Surgical removal of impacted lower third molars is a common oral surgical procedure, generally followed by moderate to severe postoperative pain. Transdermal drug delivery as a concept offers interesting possibilities for postoperative pain control. The aim of this study was to evaluate the efficacy of transdermal system with fentanyl in relieving pain following impacted lower third molar surgery. Material and Methods Seventeen patients with bilateral impacted lower third molars were included in this preliminary study. For postoperative pain control, patients randomly received a fentanyl patch plus placebo tablet after the first operation and regular (placebo) patch and an analge…

Molarmedicine.medical_specialtyTransdermal patchVisual analogue scaleAnalgesicTransdermal PatchPlaceboFentanyllaw.invention03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawmedicineHumansPain ManagementGeneral Dentistrythird molar surgeryTransdermalPain Postoperativetransdermal administrationbusiness.industryResearchTooth Impactedacute pain030206 dentistry:CIENCIAS MÉDICAS [UNESCO]postoperative care3. Good healthSurgeryAnalgesics OpioidFentanylOtorhinolaryngologyAnesthesiaTooth ExtractionUNESCO::CIENCIAS MÉDICASMolar ThirdSurgeryAnalgesiaOral Surgerybusiness030217 neurology & neurosurgerymedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine

2007

The aim of this study was to confirm that the concomitant presence of transdermal fentanyl (TTS FE) and buprenorphine (TTS BU) may be feasible without important consequences, using doses presumed to be equianalgesic. A prospective "N of 1" study was carried out in a sample of volunteers with cancer pain receiving stable doses of TTS FE or TTS BU, with adequate pain and symptom control. In the study design, each patient provided data before and after a switch from one opioid to the other and then back to the previous one. Sixteen patients receiving daily stable doses of 0.6 or 1.2 mg of TTS FE were switched to TTS BU using an FE-BU ratio of 0.6-0.8. After three days, the TTS BU patch was rem…

OralAdultMaletransdermal buprenorphinePainAdministration OralOpioidAdministration CutaneousFentanylopioid switchingNeoplasmsMedicineHumansDosingProspective StudiesCancer painNursing (all)2901 Nursing (miscellaneous)General NursingTransdermalAgedPain MeasurementIntractableAnalgesicsbusiness.industryMiddle AgedEquianalgesictransdermal fentanylBuprenorphinePain IntractableAnalgesics OpioidFentanylCutaneousAnesthesiology and Pain MedicineNeurologyOpioidConcomitantAnesthesiaCancer pain; opioid switching; transdermal buprenorphine; transdermal fentanyl; Administration Oral; Adult; Aged; Analgesics Opioid; Buprenorphine; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Pain Measurement; Pain Intractable; Prospective Studies; Administration Cutaneous; Anesthesiology and Pain Medicine; Neurology (clinical); Neurology; Nursing (all)2901 Nursing (miscellaneous)AdministrationFemaleNeurology (clinical)businessCancer painmedicine.drugBuprenorphine
researchProduct

Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.

2003

Objective To compare the long-term effects of oral and transdermal hormone replacement therapy (HRT) on serum homocysteine levels in postmenopausal women. Design An open, prospective, controlled study. Seventy-five healthy postmenopausal women were recruited as eligible for the study. Fifty women seeking HRT were randomized to receive continuous 17beta-estradiol, either by oral (2 mg daily; n = 25) or transdermal (50 microg daily; n = 25) administration, plus 10 mg dydrogesterone daily for 14 days of each 28-day cycle. Twenty-five women unwilling to receive hormone treatment received only calcium supplementation, representing the control group. Fasting blood samples were analyzed at baselin…

Oralmedicine.medical_specialtyAdministration CutaneouHomocysteineEstronemedicine.medical_treatmentHRTAdministration OralEstroneDydrogesteroneAdministration CutaneousGastroenterologylaw.inventionchemistry.chemical_compoundFollicle-stimulating hormoneRandomized controlled triallawReference ValuesInternal medicineMedicineHumansReference ValueProspective StudiesProspective cohort studyHomocysteineTransdermalEstradiolProgesterone Congenersbusiness.industryEstrogen Replacement TherapyObstetrics and GynecologyHormone replacement therapy (menopause)Progesterone CongenerMiddle AgedHomocysteine; HRT; TransdermalPostmenopauseProspective StudieEndocrinologychemistryDydrogesteroneDrug Therapy CombinationFemaleFollicle Stimulating HormonebusinessTransdermalmedicine.drugHumanMenopause (New York, N.Y.)
researchProduct

Iontophoretic Transdermal Delivery of Sumatriptan: Effect of Current Density and Ionic Strength

2005

ABSTRACT: Iontophoretic transdermal delivery of sumatriptan was investigated in vitro . Among the conditions tested, 0.25 mA/cm 2 and low ionic strength (NaCl 25 mM) was the best experimental condition to increase its transport across the skin. The flux increased 385-fold respective to passive diffusion, thus resulting in a transdermal flux of sumatriptan of 1273 ± 83 nmol/cm 2 h. © 2005 Wiley-Liss, Inc. and the American Pharmacists Association

OsmosisTime FactorsSwineSkin AbsorptionDiffusionPharmaceutical ScienceBuffersSodium ChloridePharmacologyAdministration CutaneousPharmaceutical technologymedicineAnimalsSkinTransdermalIontophoresisSumatriptanChemistryOsmolar ConcentrationEarIontophoresisLow ionic strengthSerotonin Receptor AgonistsSumatriptanIonic strengthCurrent densitymedicine.drugBiomedical engineeringJournal of Pharmaceutical Sciences
researchProduct

Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients.

2021

Abstract Background Adults with attention-deficit/hyperactivity disorder (ADHD) often face delays in diagnosis and remain untreated, despite significant negative impacts. To evaluate the safety and efficacy of transdermal treatment options in children, adolescents, and adults, a systematic literature review was conducted, with a focus on the implications of transdermal therapies for ADHD in adults. Methods A MEDLINE/Embase/BIOSIS/SCOPUS database search was conducted December 4, 2019, for English-language articles of interventional clinical trials using transdermal formulations for the treatment of ADHD without publication date limit. Assessed outcomes included efficacy, safety, adherence, a…

Pediatricsmedicine.medical_specialtyMethylphenidatebusiness.industrymedicine.diseaseDiscontinuationClinical trialPsychiatry and Mental healthSystematic reviewQuality of lifemedicineAttention deficit hyperactivity disorderNeurology (clinical)Adverse effectbusinessTransdermalmedicine.drugCNS spectrums
researchProduct

Mechanisms of gastroprotection by transdermal nitroglycerin in the rat

1999

Nitric oxide (NO) donors prevent experimentally-induced gastric mucosal damage, but their clinical utility is limited by short duration of action or unsuitability of the pharmaceutical form employed. This study analyses the gastroprotection elicited by a clinically used mode of continuous administration of an NO donor, namely the nitroglycerin patch. Application to rats of a transdermal patch that releases doses of nitroglycerin comparable to those used in man (40, 80, 160 and 400 ng min(-1) rat(-1)) reduced gastric damage induced by indomethacin (25 mg kg(-1), p.o. or s.c.). The nitroglycerin patch (160 ng min(-1) rat(-1)) also diminished damage by oral administration (1 ml) of acidified b…

PharmacologyTransdermal patchStomachPharmacologyTaurocholic acidNitric oxidechemistry.chemical_compoundmedicine.anatomical_structurechemistryPharmacokineticsOral administrationGastric mucosamedicineIntravital microscopyBritish Journal of Pharmacology
researchProduct

Sumatriptan Succinate Transdermal Delivery Systems for The Treatment of Migraine

2007

We have successfully obtained sumatriptan transdermal systems with different polymer compositions: methyl cellulose (MC), polyvinyl pyrrolidone (PVP) and a polyvinyl pyrrolidone (PVP)-polyvinyl alcohol (PVA) mixture. The systems contained 1,2-propylenglycol (MC) or sorbitol as a plasticizer (PVP and PVP-PVA), methacrylate copolymer as an adhesive agent, and an occlusive liner. Azone (5%, w/w) was incorporated into all the systems as a percutaneous enhancer. Transdermal systems are thin, transparent and non-adhesive when in a dry state. The permeation of sumatriptan succinate across pig ear skin was studied using the systems prepared. The formulation with MC polymer produced a statistically …

PolymersSwineChemistry PharmaceuticalDrug CompoundingMigraine DisordersSkin AbsorptionPharmaceutical Sciencemacromolecular substancesAbsorption (skin)MethylcellulosePharmacologyAdministration CutaneousPermeabilityDosage formchemistry.chemical_compoundPolymethacrylic AcidsPlasticizersSumatriptan SuccinatemedicineAnimalsSorbitolTechnology PharmaceuticalVasoconstrictor AgentsSkinTransdermalDrug Carriersintegumentary systemSumatriptanChemistrytechnology industry and agriculturePlasticizerPovidoneAzepinesIontophoresisPermeationPropylene GlycolSerotonin Receptor AgonistsKineticsSumatriptanPolyvinyl AlcoholMethyl celluloseDiffusion Chambers CultureTissue AdhesivesNuclear chemistrymedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Valence Topological Charge-Transfer Indices for Dipole Moments

2003

Valence topological charge-transfer (CT) indices are applied to the calculation of dipole moments. The dipole moments calculated by algebraic and vector semisums of the CT indices are defined. The combination of the CT indices allows the estimation of the dipole moments. The model is generalized for molecules with heteroatoms. The ability of the indices for the description of the molecular charge distribution is established by comparing them with the dipole moment of the valence-isoelectronic series of benzene and styrene. Two CT indices, μ v e c (vector semisum of vertex-pair dipole moments) and μ V v e c (valence μ v e c ) are proposed. μ v e c and μ V v e c are important for the predicti…

Protein ConformationHeteroatomPharmaceutical ScienceBiochemistryAnalytical ChemistryElectricityComputational chemistryDrug DiscoveryPhysicsvalence topological charge-transfer indexChemistryCharge densityGeneral Medicinemolecular charge distributionCondensed Matter Physicstransdermal drug deliveryChemistry (miscellaneous)Molecular MedicineAtomic physicsInformation SystemsSteric effectsBond dipole momentStatic ElectricityTransition dipole momentBiophysicsElectronsFractal dimensionMolecular physicsBiophysical PhenomenaArticleCatalysislcsh:QD241-441Inorganic Chemistrylcsh:Organic chemistryAtomic orbitalMoleculePhysical and Theoretical ChemistryMolecular BiologyStyreneTopological quantum numberDipole momentModels StatisticalValence (chemistry)Chemical polarityOrganic ChemistryBenzeneModels Theoreticalvalence topological chargetransfer indexElectric dipole momentDipolephenyl alcoholModels ChemicalMoment (physics)Electric dipole transitionMolecules
researchProduct